CCNE2 and hepatocellular carcinoma: Using quantitative SILAC-based proteomics and crystallography studies, they demonstrated that SIRT3 can wipe the K348 lactylation of cell cycle proteins (CCNE2) in HCC cells, thereby inhibiting the development of HCC.